Prime Capital Investment Advisors LLC reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 6.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,714 shares of the exchange traded fund’s stock after selling 377 shares during the period. Prime Capital Investment Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $565,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF during the third quarter worth about $40,000. ORG Partners LLC bought a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $40,000. ORG Wealth Partners LLC bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at approximately $44,000. Waldron Private Wealth LLC purchased a new position in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $54,000. Finally, Resources Management Corp CT ADV grew its stake in SPDR S&P Biotech ETF by 30.3% in the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 138 shares in the last quarter.
SPDR S&P Biotech ETF Stock Performance
SPDR S&P Biotech ETF stock opened at $91.88 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $69.32 and a fifty-two week high of $105.47. The stock has a market cap of $7.00 billion, a P/E ratio of 11.47 and a beta of 1.11. The firm’s fifty day moving average price is $98.95 and its 200-day moving average price is $96.03.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Dividend Capture Strategy: What You Need to Know
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- How to Use Stock Screeners to Find Stocks
- Top-Performing Non-Leveraged ETFs This Year
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
